Although an elevated expression of both cannabinoid receptors has been demonstrated in vitro in PCa cell lines compared to the expression levels in normal prostatic cells[3], most research efforts to date have concentrated on the clinical potential of CB1R in PCa. Here, CNR1 is linked to posterior cortical atrophy.